SUPPLEMENTARY METHODS

Quantitative RT-PCR analysis
T cells was generally 87% as determined by fluorescenceactivated cell sorter analysis. Total RNAs were extracted from the BMMCs of 41 patients and 20 healthy controls as well as naïve T cells and non-naïve T cells from 8 patients and 8 controls with Trizol reagent (Takara, Otsu, Japan). cDNA was prepared using a TaqMan microRNA reverse transcription kit (ABI, Foster City, USA) and a Prime Script reverse transcription reagent kit (Takara). TaqMan real-time RT-PCR was performed to confirm the expression level of miRNAs using TaqMan universal PCR master mix (ABI); U6 served as an internal control. The thermal cycling included 2 minutes at 50°C, 10 minutes at 95°C, then 40 cycles at 95°C for 15 seconds and 60°C for 1 minute. In order to verify the target genes that play a role in AA, the mRNA levels of Kruppel-like factor 4 (KLF4), lymphoid enhancer binding factor 1 (LEF1), SPI-1 protooncogene (SPI1), nuclear receptor subfamily 4 group A member 2 (NR4A2), sirtuin 1 (SIRT1), cyclin-dependent kinase 6 (CDK6), and DGKζ in BMMCs from patients and controls were measured using the SYBR Green RT-PCR Master Mix (Toyobo, Osaka, Japan). All these mRNA data were normalized to the beta-actin mRNA. The level of DGKζ mRNA in mice was examined by the same way. The thermal cycling conditions included an initial denaturation step at 95°C for 30s, followed by 40 cycles of 95°C for 5s, 62°C for 10s, and 72°C for 15s.
All reactions were performed in the light Cycler 480 II (Roche, Rotkreuz, Switzerland). Each sample was examined in triplicate. Relative transcripts were determined by the formula: 2 -(CTtarget-CTcontrol)
.
Fluorescence-activated cell sorter analysis
Cells were stained with fluorescence-labeled monoclonal antibodies (mAbs) in 100 μL cell suspensions, incubated for 30 minutes, washed, resuspended in PBS, and subsequently analyzed on a flow cytometer (Beckman Coulter, CA, USA) with Kaluza analysis software. mAbs used in mice targeted CD4, CD8, CD69, CD25, stem cell antigen 1 (Sca1), CD117 (c-kit), and the lineage cocktail (CD3, Gr-1, CD11b, CD45R and Ter-119). mAbs used for human samples targeted CD4, CD8, CD69, and CD25. Each mAb was conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PE-Cy5, PECy7, or peridinin chlorophyll protein (Percp). All mAbs were purchased from BioLegend (San Diego, CA, USA).
T cell proliferation assays
LN cells and splenocytes were similarly stimulated as above mentioned for 72 h, and during the last 12 h were pulsed with 5-Bromo-2-deoxyuridine (Brdu, BD, San Jose, USA). To track cell division, cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) prior to stimulation. Brdu incorporation and progression of cell division were analyzed by flow cytometry after staining with anti-CD4 and anti-CD8 fluorescence-labeled mAbs.
Immunoblot analysis
To determine DGKζ expression, BMMC were extracted from 8 SAA patients and 8 healthy controls, and lymph node cells from miR34a -/-mice and wild type mice were treated as method Part 'T cell activation' described. To analyze ERK activation after TCR engagement, lymph node cells from 9 miR34a -/-mice and 9 wild type mice were left unstimulated or were stimulated with anti-CD3ε and anti-CD28 mAbs for 5 and 15 min. Human BMMCs and mouse LN cells were lysed using a total protein extraction kit (BestBio, Shanghai, China). Proteins were resolved by SDS-PAGE, transferred to a trans-blot nitrocellulose membrane and probed with antibodies specific to DGKζ (Santa Cruz Biotechnology, Dallas, USA) and phosphorylated ERK1/2 (Cell Signal Technology, Danvers, MA, USA). β-actin or total ERK were determined as loading control. 
